Novartis
has recalled about 5.3 million bottles of blood-pressure
medications and other drugs that were provided as free samples to U.S.
physicians' offices, citing potential contamination by a packaging
chemical.
The bulk of the voluntary
recall, which was initiated in the summer, was for about 4.7 million
bottles of hypertension treatments Exforge and a related drug, Exforge
HCT, according to information posted online this week by the U.S. Food
and Drug Administration. Other drugs included in the recall were
blood-pressure treatments Diovan, Tekturna and Tekturna HCT; Lescol XL
cholesterol-lowering tablets; and Stalevo for Parkinson's disease.
Read more here:
http://online.wsj.com/news/articles/SB10001424052702304773104579268712087645856
